|Bid||29.00 x 1200|
|Ask||30.93 x 800|
|Day's Range||25.89 - 27.27|
|52 Week Range||24.78 - 35.40|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||1.76 (6.74%)|
|Ex-Dividend Date||May 19, 2022|
|1y Target Est||34.90|
(Bloomberg) -- Metropolis Healthcare Ltd., a diagnostics chain operating in India and Africa, is looking to raise more than $300 million and bring onboard a strategic partner by selling a significant minority stake, according to people familiar with the matter.Most Read from BloombergPlot to Kill George W. Bush in Revenge for Iraq War Was Foiled, FBI SaysBiden Demands US ‘Stand Up’ to Gun Makers After Texas AttackTexas Shooter Kills Elementary School ChildrenHungary’s Orban Declares State of Eme
TPG said on Tuesday its after-tax distributable earnings rose to $199 million in the first quarter, up from $65 million a year earlier, adding that its private equity and impact investing businesses had delivered strong growth in asset sales. TPG's result exceeded the average analyst estimate of $149 million calculated by financial data provider Refinitiv. The performance was in line with Blackstone, KKR and Carlyle, which all reported bumper profits despite soaring inflation, rising interest rates and Russia's invasion of Ukraine.
SAN FRANCISCO & FORT WORTH, Texas, May 10, 2022--TPG Inc. (NASDAQ: TPG), a leading global alternative asset management firm, reported its unaudited first quarter 2022 results. TPG issued a full detailed presentation of its quarter ended March 31, 2022 results, which can be viewed through the Investor Relations section of TPG’s website at shareholders.tpg.com.